Point72 Asset Management, L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
13.2M shares
Disclosed Ownership
1.05M shares
Ownership
8%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 04:11 PM
Date of event
Sep 30, 2025
Previous filing
Aug 5, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 8% 1.05M 0 1.05M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 8% 1.05M 0 1.05M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 8% 1.05M 0 1.05M /s/ Jason M. Colombo Jason M. Colombo, Authorized Person